Q4 2013 13F Holders as of 31 Dec 2013
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
136,051,330
-
Share change
-
+604,845
-
Total reported value
-
$1,149,653,955
-
Put/Call ratio
-
27%
-
Price per share
-
$8.44
-
Number of holders
-
217
-
Value change
-
+$5,317,163
-
Number of buys
-
9
-
Number of sells
-
5
Institutional Holders of PDL BIOPHARMA INC COM - COM (Y104L) as of Q4 2013
As of 31 Dec 2013,
PDL BIOPHARMA INC COM - COM (Y104L) was held by
217 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
136,051,330 shares.
The largest 10 holders included
Bank of New York Mellon Corp, RENAISSANCE TECHNOLOGIES LLC, BlackRock Fund Advisors, VANGUARD GROUP INC, ACADIAN ASSET MANAGEMENT LLC, SCHRODER INVESTMENT MANAGEMENT GROUP, BlackRock Institutional Trust Company, N.A., State Street Corp, Gotham Asset Management, LLC, and Advisors Asset Management, Inc..
This page lists
217
institutional shareholders reporting positions in this security
for the Q4 2013 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.